Znanstveni rad - Pregledni rad
Conventional disease-modifying agents in rheumatoid arthritis – a review of their current use and role in treatment algorithms
Reumatologia/Rheumatology, 58 (2020), 6; 390-400. https://doi.org/10.5114/reum.2020.101400

Padjen, Ivan; Reihl Crnogaj, Mirna; Anić, Branimir

Citirajte ovaj rad

Padjen, I., Reihl Crnogaj, M. i Anić, B. (2020). Conventional disease-modifying agents in rheumatoid arthritis – a review of their current use and role in treatment algorithms. Reumatologia/Rheumatology, 58. (6), 390-400. doi: 10.5114/reum.2020.101400

Padjen, Ivan, et al. "Conventional disease-modifying agents in rheumatoid arthritis – a review of their current use and role in treatment algorithms." Reumatologia/Rheumatology, vol. 58, br. 6, 2020, str. 390-400. https://doi.org/10.5114/reum.2020.101400

Padjen, Ivan, Mirna Reihl Crnogaj i Branimir Anić. "Conventional disease-modifying agents in rheumatoid arthritis – a review of their current use and role in treatment algorithms." Reumatologia/Rheumatology 58, br. 6 (2020): 390-400. https://doi.org/10.5114/reum.2020.101400

Padjen, I., Reihl Crnogaj, M. i Anić, B. (2020) 'Conventional disease-modifying agents in rheumatoid arthritis – a review of their current use and role in treatment algorithms', Reumatologia/Rheumatology, 58(6), str. 390-400. doi: 10.5114/reum.2020.101400

Padjen I, Reihl Crnogaj M, Anić B. Conventional disease-modifying agents in rheumatoid arthritis – a review of their current use and role in treatment algorithms. Reumatologia/Rheumatology [Internet]. 2020. [pristupljeno 19.05.2022.];58(6):390-400. doi: 10.5114/reum.2020.101400

I. Padjen, M. Reihl Crnogaj i B. Anić, "Conventional disease-modifying agents in rheumatoid arthritis – a review of their current use and role in treatment algorithms", Reumatologia/Rheumatology, vol. 58, br. 6, str. 390-400, 2020. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:515748. [Citirano: 19.05.2022.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.